Error: Could not add to watchlist. X

UBS Lux Equity Fund - Biotech USD

+ Watchlist
UBSEBIO:LX
655.26
USD
0.64
0.10%
As of 00:59:30 ET on 07/30/2015.
Fund Type
FCP
52Wk Range
454.18 - 696.30
1 Yr Return
44.27%
YTD Return
17.25%
Previous Close
654.62
52Wk Range
454.18 - 696.30
1 Yr Return
44.27%
YTD Return
17.25%
Fund Type
-
Objective
-
Asset Class Focus
-
Geographic Focus
-
NAV (on 07/30/2015)
655.26
Total Assets (b USD) (on 07/30/2015)
1.772
Inception Date
10/15/1996
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Fund Managers
NATHALIE LOTSCHER PETRUS / SARAH COTTER
Front Load Fee
2.00%
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
1.63%
Expense Ratio
2.08%
Top Fund Holdings
Name Position Value % of Fund
Gilead Sciences Inc 1.52 m 171.10 m 9.58
Biogen Inc 420.73 k 167.03 m 9.36
Amgen Inc 893.93 k 139.69 m 7.82
Celgene Corp 952.72 k 109.03 m 6.11
BioMarin Pharmaceutical Inc 824.41 k 103.52 m 5.80
Regeneron Pharmaceuticals Inc 167.89 k 86.05 m 4.82
Vertex Pharmaceuticals Inc 670.02 k 85.96 m 4.82
Incyte Corp 683.40 k 75.28 m 4.22
Alexion Pharmaceuticals Inc 447.60 k 73.34 m 4.11
Medivation Inc 522.80 k 69.04 m 3.87
Profile
UBS Lux Equity Fund - Biotech USD is an open-end investment fund incorporated in Luxembourg. The Fund's objective is medium- to long-term capital growth. The Fund invests globally in equities of companies engaged in research, product development, product manufacturing and distribution in the biotechnology sector.
ADDRESS
UBS Equity Fund Management Company
33A avenue J.F. Kennedy
L-1855 Luxembourg
Luxembourg
PHONE
352-44-10-10-1 Tel